| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc8b706fb22ca0baba35f66ce3e501ef |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate |
2021-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1106c8610be060fa26a27fad6f92fbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79515248e73960ea15389af28a3de89d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04a2e6b3922569cd455e8907c06c935f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_428f849f53e90322d9dae44bfcfe9041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b289c72c25b54833dabee5b3b545783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adb8bf5be0da7e99b3a9abf3f66e3797
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f833a65cd89f985547389034da3b89e1 |
| publicationDate |
2021-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021175295-A1 |
| titleOfInvention |
Application of myricetin compound in preparation of drugs for prevention and treatment of novel coronavirus pneumonia |
| abstract |
Application of a myricetin compound in the preparation of drugs for prevention and treatment of novel coronavirus pneumonia. Specifically, the present invention relates to use of a myricetin compound and a pharmaceutical composition as a 2019 novel coronavirus (SARS-CoV-2) 3CL protease inhibitor in the preparation of drugs for treatment and/or prevention and alleviation of related diseases such as respiratory tract infections and pneumonia caused by 2019 novel coronavirus infections. |
| priorityDate |
2020-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |